2016 - Member of the National Academy of Medicine (NAM)
Member of the Association of American Physicians
Immunology, Cytotoxic T cell, Antigen, Immunotherapy and Transplantation are his primary areas of study. Immunology is closely attributed to Hematopoietic stem cell transplantation in his work. He has included themes like Cancer research and Virology in his Cytotoxic T cell study.
He works mostly in the field of Antigen, limiting it down to concerns involving Chimeric antigen receptor and, occasionally, CD30, Antibody and Receptor. His research investigates the connection with Immunotherapy and areas like Neuroblastoma which intersect with concerns in Bone marrow neoplasm. His Transplantation research is multidisciplinary, incorporating perspectives in Stem cell and Bone marrow.
Malcolm K. Brenner spends much of his time researching Immunology, Antigen, Cytotoxic T cell, Cancer research and Immunotherapy. His study looks at the relationship between Immunology and fields such as Transplantation, as well as how they intersect with chemical problems. Malcolm K. Brenner interconnects Molecular biology, Chimeric antigen receptor, Antibody and Virology in the investigation of issues within Antigen.
His biological study spans a wide range of topics, including Epstein–Barr virus and CD8. His Cancer research research integrates issues from Cytokine, CD40, Receptor, Suicide gene and Leukemia. His work on Lymphoma expands to the thematically related Immunotherapy.
Malcolm K. Brenner mainly focuses on Cancer research, Immunology, Chimeric antigen receptor, Antigen and T cell. His Cancer research research is multidisciplinary, incorporating elements of Cell culture, Receptor and Immunotherapy. His Immunotherapy research is multidisciplinary, relying on both Transgene and In vivo.
His research in Immunology intersects with topics in Cytotoxic T cell and Hematopoietic stem cell transplantation. His studies in Chimeric antigen receptor integrate themes in fields like Progenitor cell, Cell, Cytokine and CD30. His work deals with themes such as Chemotherapy, PRAME, Lymphoma, Leukemia and Tumor antigen, which intersect with Antigen.
Malcolm K. Brenner mainly investigates Cancer research, Chimeric antigen receptor, Immunology, Antigen and T cell. His Cancer research research includes elements of Cytokine receptor and Immunotherapy. His Chimeric antigen receptor research incorporates elements of Cytokine, Progenitor cell, CD28, Myeloid leukemia and Lymphoma.
The various areas that Malcolm K. Brenner examines in his Immunology study include Hematopoietic stem cell and Suicide gene. His Antigen study integrates concerns from other disciplines, such as Cell culture, Leukemia, Tumor antigen and CD30. The study incorporates disciplines such as Cytotoxic T cell, CD5, Long terminal repeat and Cell biology in addition to T cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
Edwin M. Horwitz;Darwin J. Prockop;Lorraine A. Fitzpatrick;Winston W. K. Koo.
Nature Medicine (1999)
A distinct "side population" of cells with high drug efflux capacity in human tumor cells.
C. Hirschmann-Jax;Aaron E. Foster;G. G. Wulf;G. G. Wulf;J. G. Nuchtern.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.
C.M Rooney;C.Y.C Ng;S Loftin;C.A Smith.
The Lancet (1995)
Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients
Cliona M. Rooney;Colton A. Smith;Colton A. Smith;Catherine Y.C. Ng;Catherine Y.C. Ng;Susan K. Loftin;Susan K. Loftin.
Inducible apoptosis as a safety switch for adoptive cell therapy
Antonio Di Stasi;Siok Keen Tey;Gianpietro Dotti;Yuriko Fujita.
The New England Journal of Medicine (2011)
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
M.K Brenner;D.R Rill;R.A Krance;J.N Ihle.
The Lancet (1993)
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
Martin A. Pule;Barbara Savoldo;G. Doug Myers;G. Doug Myers;Claudia Rossig.
Nature Medicine (2008)
CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
Barbara Savoldo;Carlos Almeida Ramos;Carlos Almeida Ramos;Enli Liu;Martha P. Mims.
Journal of Clinical Investigation (2011)
Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma
Chrystal U. Louis;Chrystal U. Louis;Barbara Savoldo;Barbara Savoldo;Gianpietro Dotti;Gianpietro Dotti;Martin Pule.
Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes
Helen E. Heslop;Catherine Y.C. Ng;Congfen Li;Colton A. Smith.
Nature Medicine (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: